Absci and EQRx in tie-up to accelerate production of cheaper, protein based therapeutics

Retrieved on: 2021-10-06 14:26:15

Tags for this article:

Health sciences

Life Sciences

Pharmaceutical sciences

Drug discovery

Biopharmaceutical

Biotechnology

Pharmaceutical industry

Pharmacy

Druggability

AbSci

Click the tags to see associated articles and topics

Absci and EQRx in tie-up to accelerate production of cheaper, protein based therapeutics. View article details on hiswai:

Excerpt

Sean McClain, founder and CEO of Absci, told BioPharma-Reporter: "EQRx came to us specifically to take advantage of our ability to rapidly discover new ...

Article found on: www.biopharma-reporter.com

View Original Article